47260-5

Plasmodium sp DNA [Identifier] in Blood by NAA with probe detection

Active

Part Descriptions

LP14840-0   Plasmodium sp
A genus of coccidian protozoa that comprise the malaria parasites of mammals. Four species infect humans (although occasional infections with primate malarias may occur). These are PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI; and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens. Source: National Library of Medicine, MeSH 2006

LP14840-0   Plasmodium sp
Plasmodium is a genus of parasitic protozoa. Infection by this parasite is known to cause malaria. The genus Plasmodium was discovered in 1885 by Marchiafava and Celli. Currently over 200 species of this genus are recognized and new species continue to be described.

Of over the 200 known species of Plasmodium, at least 10 species infect humans. Other species infect animals, including monkeys, rodents, birds, and reptiles. The parasite always has two hosts in its life cycle: a mosquito vector and a vertebrate host. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Plasmodium sp

LP20149-8   Plasmodium
Malaria is a parasitic disease that is passed from one human to another by the bite of an infected Anopheles mosquito with one of four protozoan parasites: Plasmodium falciparum, vivax, malariae or ovale. The parasites enter the bloodstream and infect red blood cells where they multiply and infect more red blood cells. Symptoms usually occur 10 days to 4 weeks after infection and include anemia, high fevers, shaking chills, muscle pain, and nausea. Antimalarial agents used to treat malaria include Quinine, Quinidine, Mefloquine, Chloroquine, and Hydroxychloroquine. The effectiveness of the agents depends on which phase or phases of the Plasmodium life cycle is interrupted. In most cases, treatment outcome is expected to be good except in cases of a p. falciparum infection. Adverse effects from antimalaria medications include vomiting, diarrhea, headaches, cardiac arrhythmias, EKG abnormalities, deafness, damage to liver and kidney and muscle weakness. Source: NMS labs

Fully-Specified Name

Component

Plasmodium sp DNA

Property

Prid

Time

Pt

System

Bld

Scale

Nom

Method

Probe.amp.tar

Additional Names

Short Name

Plasmodium DNA Bld NAA+probe

Display Name

Plasmodium sp DNA NAA+probe Nom (Bld)

Consumer Name Alpha Get Info

Plasmodium sp, Blood

Example Answer List: LL2041-3

Basic Attributes

Class

MICRO

Type

Laboratory

First Released

Version 2.19

Last Updated

Version 2.73

Order vs. Observation

Both

Common Test Rank Get Info

12344

Member of these Groups Get Info

Language Variants Get Info

Related Names

• 3 Self-Sustaining Sequence Replication
• 3SR SR
• Amplif
• Amplification
• Amplified
• Blood
• Deoxyribonucleic acid
• DNA NUCLEIC ACID PROBE
• DNA probe
• ID
• Identity or presence
• Infectious Disease
• InfectiousDisease
• LAT
• LCR
• Ligase chain reaction
• Ligation-activated transcription
• Malaria
• Malarial
• Microbiology
• NAA+probe
• NAAT
• NASBA
• Nominal
• Nucleic acid sequence based analysis
• PCR
• Plasmodium DNA
• Point in time
• Polymerase chain reaction
• Probe amp
• Probe with ampification
• Probe with target amplification
• QBR
• Random
• SDA
• species
• spp
• Strand Displacement Amplification
• TMA
• Transcription mediated amplification
• WB
• Whole blood

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=47260-5

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.